2
Clinical Trials associated with Suftalan Zinc在晚期肿瘤病人中进行的单剂量静脉内给予福大赛因注射液的单中心I期临床研究
[Translation] A single-center phase I clinical study of a single-dose intravenous forsine injection in patients with advanced tumors
确定单次剂量给药在人体的安全性和耐受性;描述单次给药后该药物及其代谢物人体内的药代动力学规律并计算药代参数,分析药代动力学参数与毒性的关系,初步探讨PK-PD;为Ⅱ期临床研究提供安全有效的合理给药试验方案。
[Translation] Determine the safety and tolerability of a single dose in humans; describe the pharmacokinetic laws of the drug and its metabolites in humans after a single dose and calculate pharmacokinetic parameters, analyze the relationship between pharmacokinetic parameters and toxicity, and preliminarily explore PK-PD; provide a safe and effective reasonable dosing test plan for Phase II clinical studies.
Start Date- |
Sponsor / Collaborator- |
评价用福大赛因注射液光动力治疗完全或不完全梗阻原发性食管癌患者有效性安全性的开放多中心II期临床试验
[Translation] An open multicenter phase II clinical trial to evaluate the effectiveness and safety of photodynamic therapy with forsine injection in patients with complete or incomplete obstruction of primary esophageal cancer
主要目的:评价福大赛因注射液对于改善食管阻塞和吞咽困难症状的疗效。 次要目的:评价福大赛因注射液治疗前后肿瘤病灶缩小情况;评价福大赛因注射液治疗前后生活质量改善情况;评价福大赛因注射液治疗的安全性及潜在操作风险的控制。
[Translation] Primary objective: To evaluate the efficacy of Fosdaigin injection in improving esophageal obstruction and dysphagia. Secondary objectives: To evaluate the reduction of tumor lesions before and after Fosdaigin injection treatment; to evaluate the improvement of quality of life before and after Fosdaigin injection treatment; to evaluate the safety of Fosdaigin injection treatment and the control of potential operational risks.
100 Clinical Results associated with Suftalan Zinc
100 Translational Medicine associated with Suftalan Zinc
100 Patents (Medical) associated with Suftalan Zinc
100 Deals associated with Suftalan Zinc